Join the Austrian myeloid patient registry
Part of Blood & lymphatic, Cancer clinical trials.
This is a registry study that collects information from people with myeloid blood diseases. It helps researchers better understand these conditions and support future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 17 years
- Have a diagnosis of a myeloid blood disease
- Get a doctor to confirm the diagnosis matches the study’s criteria
- Be able and willing to sign the study consent form (informed consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a cancer registry that collects information from people with lymphoma, Hodgkin disease, or myeloma. It helps researchers understand these cancers better by using real-world patient data.
This study keeps a patient registry to collect information about people with specific myeloid blood neoplasms (a type of blood cancer). It helps researchers understand these conditions over time and may improve how patients are cared for in the future.
This registry collects information from adults with lymphoma to better understand the disease and improve future treatments. It is open to all patients 18 or older with lymphoma.
This is a registry (a study that collects health information over time) for adults with suspected or confirmed blood cancers of the myeloid type. It aims to better understand the biology of these illnesses and how different factors affect outcomes, which may improve care in the future.
This study creates a real-world registry (a group database) of people with active, symptomatic multiple myeloma. It helps researchers learn from patients and doctors over time and may support future research and treatment improvements.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
Hear when a new Myeloid Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.